Borgeson Blakeinsider trades

In SEC Form 4 filings, Borgeson Blake is listed as Director of Recursion Pharmaceuticals, Inc. (RXRX). In the last 90 days, Borgeson Blake sold $342.2K of Recursion Pharmaceuticals, Inc. (RXRX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
RXRXRecursion Pharmaceuticals, Inc.	Director	2	Oct 7

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RXRXRecursion Pharmaceuticals, Inc.	Oct 6	Oct 7	S	50,000	$4.84	Sale −$242,000	6,108,287	Yes	Form 4
RXRXRecursion Pharmaceuticals, Inc.	Sep 1	Sep 2	S	30,000	$3.34	Sale −$100,200	6,158,287	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.